Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DOLPHIN-HEALTHCARE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.6%   Bankruptcy risk   9.1% 4.4% 6.2% 11.7% 3.6% 3.0% 12.2% 9.0%   Credit score (0-100)   29 48 39 20 51 57 1 1   Credit rating   BB BBB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   283 405 521 424 1,179 903 0.0 0.0   EBITDA   239 355 454 302 1,065 297 0.0 0.0   EBIT   239 355 454 302 1,065 297 0.0 0.0   Pre-tax profit (PTP)   235.5 353.6 451.5 298.0 1,057.3 283.7 0.0 0.0   Net earnings   182.9 275.5 352.0 232.3 824.3 220.1 0.0 0.0   Pre-tax profit without non-rec. items   235 354 451 298 1,057 284 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   377 546 790 912 1,623 1,729 1,561 1,561   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   568 759 1,024 1,067 2,088 1,889 1,561 1,561   Net Debt   -360 -504 -608 -532 -1,204 -496 -1,561 -1,561     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   283 405 521 424 1,179 903 0.0 0.0   Gross profit growth   216.2% 42.8% 28.6% -18.5% 178.0% -23.4% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   568 759 1,024 1,067 2,088 1,889 1,561 1,561   Balance sheet change%   44.0% 33.5% 35.0% 4.2% 95.7% -9.5% -17.4% 0.0%   Added value   239.0 355.3 454.4 302.3 1,065.4 297.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   84.3% 87.8% 87.3% 71.3% 90.4% 32.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   49.6% 53.5% 51.0% 28.9% 67.5% 15.0% 0.0% 0.0%   ROI %   83.8% 77.0% 68.0% 35.5% 84.1% 17.7% 0.0% 0.0%   ROE %   64.2% 59.7% 52.7% 27.3% 65.0% 13.1% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   66.2% 72.0% 77.1% 85.5% 77.7% 91.5% 100.0% 50.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -150.5% -141.8% -133.7% -176.0% -113.0% -166.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   2.1 2.7 3.0 4.3 2.6 3.4 0.0 0.0   Current Ratio   3.0 3.6 4.4 6.9 4.4 11.7 0.0 0.0   Cash and cash equivalent   359.7 503.7 607.6 532.2 1,204.0 496.4 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   376.6 546.2 790.2 911.9 1,600.9 1,706.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   239 355 454 302 1,065 297 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   239 355 454 302 1,065 297 0 0   EBIT / employee   239 355 454 302 1,065 297 0 0   Net earnings / employee   183 275 352 232 824 220 0 0